Jinan Ma
Impact in
- Health Informatics top 10%
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Oncology 23
- Lung Cancer Research Studies 7
- Inflammatory Biomarkers in Disease Prognosis 6
- Cancer Immunotherapy and Biomarkers 6
-
- Sarcoma Diagnosis and Treatment 3
- Co-authors
- Chunhong Hu (17 shared papers)Tao Hou (9 shared papers)Fangwen Zou (8 shared papers)Shun Jiang (6 shared papers)Yapeng Wang (4 shared papers)Haixia Zhang (1 shared paper)Wenhao Luo (1 shared paper)Fang Ma (3 shared papers)
- Journals
- Medicine (3 papers)Frontiers in Oncology (3 papers)Journal of Clinical Oncology (2 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Jinan Ma
38 papers receiving 389 citations
Peers
Comparison fields: 5 of 72
- Health Informatics 12
- Cancer Research 111
- Oncology 174
- Otorhinolaryngology 24
- Pulmonary and Respiratory Medicine 101
Countries citing papers authored by Jinan Ma
This map shows the geographic impact of Jinan Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinan Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinan Ma more than expected).
Fields of papers citing papers by Jinan Ma
This network shows the impact of papers produced by Jinan Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinan Ma. The network helps show where Jinan Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Jinan Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 45 | |
| 2 | 2020 | 41 | |
| 3 | 2020 | 35 | |
| 4 | 2019 | 29 | |
| 5 | 2020 | 25 | |
| 6 | 2021 | 19 | |
| 7 | 2014 | 18 | |
| 8 | 2024 | 17 | |
| 9 | 2015 | 17 | |
| 10 | 2018 | 16 | |
| 11 | Decitabine reverses gefitinib resistance in PC9 lung adenocarcinoma cells by demethylation of RASSF1A and GADD45β promoter. | 2019 | 14 |
| 12 | 2022 | 12 | |
| 13 | 2020 | 10 | |
| 14 | 2021 | 10 | |
| 15 | 2020 | 10 | |
| 16 | 2020 | 9 | |
| 17 | 2015 | 8 | |
| 18 | 2022 | 6 | |
| 19 | 2014 | 6 | |
| 20 | 2020 | 6 |
About Jinan Ma
Jinan Ma is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Cancer Research, having authored 43 papers that have together received 397 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (7 papers), Inflammatory Biomarkers in Disease Prognosis (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Head and Neck Cancer Studies (5 papers), Circular RNAs in diseases (3 papers), MicroRNA in disease regulation (3 papers), Cancer-related molecular mechanisms research (3 papers) and Sarcoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Health Informatics (12 citations), Cancer Research (111 citations), Oncology (174 citations), Otorhinolaryngology (24 citations) and Pulmonary and Respiratory Medicine (101 citations). Jinan Ma has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Chunhong Hu, Tao Hou, Fangwen Zou, Shun Jiang, Yapeng Wang, Haixia Zhang, Wenhao Luo, Fang Ma, Yuhua Feng and Yeqian Feng. Their work appears in journals such as Medicine, Frontiers in Oncology, Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.